Dr Jervin Lim combines advanced diagnostic technologies with integrative medicine expertise to deliver personalised, evidence-informed care
Cancer patients often endure a frustrating cycle of trial-and-error chemotherapy that fails to guarantee results and can cause harmful side effects. In contrast, precision testing offers a more efficient and targeted approach by identifying the most effective treatment for each patient.
This personalized strategy avoids unnecessary trials, reduces side effects, and ultimately improves the overall treatment experience and quality of life.
In the fight against cancer, early detection and personalized treatment are crucial. Dr. Jervin Lim offers a suite of innovative cancer testing services designed to provide comprehensive insights into your cancer, enabling healthcare providers to develop tailored treatment plans for the best possible outcomes.
Onco-D-clare
Oncotrace
Onconomics Plus
CTC count is a measure of the volume of circulating cancer cells in a body. When a treatment is given, these CTCs are affected by the treatment, and their enumeration is used as an indicator of the treatment's effectiveness in reducing tumor burden
Cancer cells tend to express themselves genetically like normal cells. Learning the gene expression of cancer cells reveals how they quickly adapt to become resistant to treatment. Understanding this can inform treatment strategies, allowing for more frequent rotations in protocols to outpace resistance
A particular chemotherapeutic agent or targeted drug may not work for everyone. Whether it effectively targets cancer cells or not, it takes a toll on the body. Knowing the specific chemotherapeutic agents and drugs that target cancer cells better not only reduces the burden but also eliminates the uncertainty in selecting effective treatments
Many natural substances are said to have cancer-targeting properties but not all work the same for everyone. Evaluating the substance that targets cancer and works effectively helps in taking out the guesswork of treatment effectiveness
Whole peripheral blood sample
15-25ml blood, minimum 400mg tissue
10-12 days in the lab
21 days after sample collection
Applicable for all cancer types
The test is useful for patients looking to decide on the right treatment.
Dr Jervin Lim has extensive experience working with RGCC liquid biopsy tests, using them to assess circulating tumor cells, treatment sensitivity, and disease dynamics. He integrates RGCC results into personalised care strategies, translating complex molecular data into clear, actionable insights that support treatment planning, monitoring, and long-term management alongside conventional oncology care.
_____
Schedule your consultation with Dr. Jervin Lim and discover how personalized metabolic therapy and RGCC testing can support your health goals.
